Source:http://linkedlifedata.com/resource/pubmed/id/19153467
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 1
|
pubmed:dateCreated |
2009-1-20
|
pubmed:databankReference | |
pubmed:abstractText |
The inhibitor of apoptosis protein (IAP) family of molecules inhibit apoptosis through the suppression of caspase activity. It is known that the XIAP protein regulates both caspase-3 and caspase-9 through direct protein-protein interactions. Specifically, the BIR3 domain of XIAP binds to caspase-9 via a ;hotspot' interaction in which the N-terminal residues of caspase-9 bind in a shallow groove on the surface of XIAP. This interaction is regulated via SMAC, the N-terminus of which binds in the same groove, thus displacing caspase-9. The mechanism of suppression of apoptosis by cIAP1 is less clear. The structure of the BIR3 domain of cIAP1 (cIAP1-BIR3) in complex with N-terminal peptides from both SMAC and caspase-9 has been determined. The binding constants of these peptides to cIAP1-BIR3 have also been determined using the surface plasmon resonance technique. The structures show that the peptides interact with cIAP1 in the same way that they interact with XIAP: both peptides bind in a similar shallow groove in the BIR3 surface, anchored at the N-terminus by a charge-stabilized hydrogen bond. The binding data show that the SMAC and caspase-9 peptides bind with comparable affinities (85 and 48 nM, respectively).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Multiprotein Complexes,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/SMAC peptide,
http://linkedlifedata.com/resource/pubmed/chemical/X-Linked Inhibitor of Apoptosis...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1399-0047
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
58-66
|
pubmed:meshHeading |
pubmed-meshheading:19153467-Animals,
pubmed-meshheading:19153467-Apoptosis,
pubmed-meshheading:19153467-Binding Sites,
pubmed-meshheading:19153467-Caspase 9,
pubmed-meshheading:19153467-Crystallization,
pubmed-meshheading:19153467-Crystallography, X-Ray,
pubmed-meshheading:19153467-Humans,
pubmed-meshheading:19153467-Hydrogen Bonding,
pubmed-meshheading:19153467-Multiprotein Complexes,
pubmed-meshheading:19153467-Oligopeptides,
pubmed-meshheading:19153467-Protein Binding,
pubmed-meshheading:19153467-Protein Structure, Tertiary,
pubmed-meshheading:19153467-Structural Homology, Protein,
pubmed-meshheading:19153467-Surface Plasmon Resonance,
pubmed-meshheading:19153467-X-Linked Inhibitor of Apoptosis Protein
|
pubmed:year |
2009
|
pubmed:articleTitle |
The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
|
pubmed:affiliation |
Novartis Institutes for Biomedical Research Inc., USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|